TALIS BIOMEDICAL CORP's ticker is TLIS and the CUSIP is 87424L108. A total of 21 filers reported holding TALIS BIOMEDICAL CORP in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 2,235,783 | $1,073,176 | 0.05% |
| GEODE CAPITAL MANAGEMENT, LLC | 140,530 | $67,454 | 0.00% |
| BlackRock Inc. | 76,307 | $36,628 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 10,476 | $5,028 | 0.00% |
| UBS Group AG | 26 | $12 | 0.00% |
| NORTHERN TRUST CORP | 27,860 | $13,373 | 0.00% |
| Renaissance Technologies | 54,900 | $26 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 91,463 | $43,902 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 49,007 | $23,523 | 0.00% |
| Citadel Advisors | 27,900 | $13,392 | 0.00% |
| Citadel Advisors | 38,876 | $18,660 | 0.00% |
| Tower Research Capital LLC (TRC) | 273 | $131 | 0.00% |
| STATE STREET CORP | 47,436 | $22,769 | 0.00% |
| DEUTSCHE BANK AG\ | 45,294 | $21,741 | 0.00% |
| MORGAN STANLEY | 61,857 | $29,691 | 0.00% |
| ROYAL BANK OF CANADA | 150 | $0 | 0.00% |
| VANGUARD GROUP INC | 466,336 | $223,841 | 0.00% |
| WELLS FARGO & COMPANY/MN | 174 | $84 | 0.00% |
| New England Capital Financial Advisors LLC | 10 | $5 | 0.00% |
| Larson Financial Group LLC | 200 | $96 | 0.00% |
External links
This page lists TALIS BIOMEDICAL CORP's shareholders in Q2 2023. To view TALIS BIOMEDICAL CORP's shareholder history, click here.